Skip to content

CODEMA PHARMA

Active
Public limited companyfounded 2017active for 9 yearsRobert Schumanplein 2-4, 1040 Brussel, BelgiumKBO/BCE: BE 0678.830.942
Summary

The computed 12-month bankruptcy probability of CODEMA PHARMA is 5.9% (elevated). The 2025 annual accounts show equity of €71,289 and a net result of -€32,963. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 12,482 sector peers (NACE 47, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€375,959total assets 2025
Equity
€71,289
Loss
-€32,963
Turnover not published (abbreviated or micro format)
Financial health
34 Weak Checked score 2025
Bankruptcy probabilitywithin 12 months
5.9%
Structure
Accounts filed 31 days late1 of 4 deeds read
Why 34raises riskLatest accounts 31 days late; 1 of the last 3 lateEx-officio strike-off in the KBOLoss of €32,963, the second in a row (financial year 2025)1 change of registered office in 24 monthsShow the evidence

Checked score

Score 2025
34 / 100
Weak
Probability in this band: 4.2% to 15.0%
Financially better than 19% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 44-6
equity 19.0% of total assets
Liquidity 6-4
short-term debt 81.0% · cash 0.6%
Profitability 16-16
return on assets -8.8%
Bankruptcy probability, 12 months
5.9% Elevated
0%0.5%1.5%4%10%≥ 25%

About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,186 companies, NACE 47, micro)
Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.7%● unchanged vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.8%▲ +0.1 percentage points vs 06-2025 08-2025: 0.7%▼ -0.1 percentage points vs 07-2025 09-2025: 0.6%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: 0.6%● unchanged vs 09-2025lowest value 11-2025: 0.6%● unchanged vs 10-2025lowest value 12-2025: 1.1%▲ +0.5 percentage points vs 11-2025 01-2026: 1.1%● unchanged vs 12-2025 02-2026: 1.1%● unchanged vs 01-2026 03-2026: 1.1%● unchanged vs 02-2026 04-2026: 2.0%▲ +0.9 percentage points vs 03-2026 05-2026: 2.4%▲ +0.4 percentage points vs 04-2026 06-2026: 2.4%● unchanged vs 05-2026 07-2026: 2.5%▲ +0.1 percentage points vs 06-2026 08-2026: 3.6%▲ +1.1 percentage points vs 07-2026 09-2026: 5.9%▲ +2.3 percentage points vs 08-2026highest value 10-2026: 5.9%● unchanged vs 09-2026highest value
Credit of up to €2,000 on 30-day terms, only on tighter conditions
Liquidity tight (current ratio 1.23, compared with 1.35 in 2024; short-term debt: 81% and cash: 0.6% of total assets), and 81% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 35% on solvency, 8% on liquidity, 20% on profitability and 15% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
+raises risk○neutral
raises risk · Latest accounts 31 days late; 1 of the last 3 late
NBB · filings
raises risk · Ex-officio strike-off in the KBO
KBO publications
raises risk · Loss of €32,963, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€32,963
neutral · A punctual record breaks
This company filed 7 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are in a legal situation other than normal, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 9 filings
Deviation from the deadline
2025
31 days late
2024
17 days early
2023
7 days early
2022
7 days early
2021
5 days early
2020
8 days early
2019
7 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publications
Publications
Address struck
Searched, nothing found (1)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Registered officeRegistered-office move
  3. Address struckKBO administration

Key points

  • Caution: Among the weakest 11% on net resultsector median €28,206 · 12,471 companies -€32,963 View
  • Caution: 2 loss-making years in a rowloss financial year 2025 -€32,963 View
  • Total assets 20256 financial years filed €375,959 View

By topic

Financials

Financial year
2025
Total assets
€375,959
Loss
-€32,963
Solvency
19.0%
Turnover▲ 1,115%
Net result
20182020
Go to Financials

Timeline

Events
15
Since
2018
Next accounts
by 31-07-2027
  1. 14-07-2025Annual accounts filed
  2. 24-07-2024Annual accounts filed
  3. 31-12-2023Back to profit
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
25-07-2017
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.